{
  "retracted": false,
  "timestamp": 1556668800000,
  "updates": [
    {
      "timestamp": 1574878517443,
      "identifier": {
        "doi": "10.1016/j.colsurfb.2019.01.063"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.colsurfb.2015.04.050"
  },
  "journal": "Colloids and Surfaces B: Biointerfaces",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “PEGylated ofloxacin nanoparticles render strong antibacterial activity against many clinically important human pathogens” [Colloids Surf. B: Biointerfaces 132 (2015) 62–70]"
}
